Synthetic Biology Market Forecast: 25.6% CAGR to Accelerate Growth During 2022-2027

Synthetic Biology Market in terms of revenue was estimated to be worth $11.4 billion in 2022 and is poised to reach $35.7 billion by 2027, growing at a CAGR of 25.6% from 2022 to 2027 according to a new report by MarketsandMarkets™. Synthetic biology is a rapidly growing field of science that combines engineering principles with biotechnology to create new biological products and processes. It is a field of biotechnology that makes use of engineering and information technology to design and construct new biological systems from a variety of components. The global Synthetic Biology Market is expected to witness significant growth over the forecast period, primarily due to the increasing demand for synthetic biology-based products and services in the industrial and medical sectors.

The key applications of synthetic biology include drug development, diagnostics, gene synthesis, metabolic engineering, bioproduction, and bioremediation. The increasing demand for the production of affordable, high-quality drugs and other products has propelled the growth of the synthetic biology market. The advancements in genetic engineering technologies and the increasing demand for personalized medicines are expected to further drive the growth of the market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

The increasing interest of venture capitalists and governments in the field of synthetic biology is providing an impetus to the growth of the market. Several government initiatives and venture capital investments are being made in the field, which is expected to propel the growth of the synthetic biology market. In addition, the increasing demand for biofuels and the growing demand for advanced biologics are expected to propel the growth of the market.

However, the limited availability of skilled professionals and the high cost of research and development are expected to restrain the growth of the market. Moreover, stringent regulations regarding the use of synthetic biology products and services are expected to pose a challenge to the growth of the market.

Synthetic Biology Market Dynamics:

Drivers:

• Diverse applications of synthetic biology
• Increased funding for research in synthetic biology
• Declining cost of DNA sequencing and synthesizing
• Innovations in synthetic biology

Restraints:

Biosafety, biosecurity, and ethical concerns

Opportunities:

• Increasing demand for fuel alternatives
• Growth in research on synthetic drugs and vaccines
• Use of machine learning in research and development

Challenges:

Standardization of biological parts

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

Key Market Players:

Some of the prominent players in the synthetic biology market are Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Agilent Technologies (US), Novozymes (Denmark), Ginkgo Bioworks (US), Amyris (US), Precigen, Inc. (US), GenScript (China), Twist Bioscience (US), Synthetic Genomics (US), Codexis (US), Synthego (US), Creative Enzymes (US), and among others.

Recent Developments:

• In January 2021, Novozymes launched Frontia GlutenEx. It would help wheat processors increase their gluten protein recovery and, at the same time, cut down on energy consumption.
• In February 2021, Merck partnered with BioNTech (Germany) to supply lipids for the production of Pfizer-BioNTech COVID-19 Vaccine (BNT162b2).
• In January 2021, Merck acquired AmpTec (Germany). With this acquisition, the company strengthened its product portfolio to develop and manufacture mRNA for utilizing vaccines, treatments, and diagnostics.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889

About MarketsandMarkets™:

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Article source: https://article-realm.com/article/Health-Fitness/Exercise/36969-Synthetic-Biology-Market-Forecast-25-6-CAGR-to-Accelerate-Growth-During-2022-2027.html